Results 21 to 30 of about 1,862,216 (244)

The future of drug eluting stents [PDF]

Heart, 2005
In-stent restenosis (ISR) is the major drawback of percutaneous coronary interventions, occurring in 10–40% of patients. Drug eluting stents (DES) are successful in a large majority of patients in preventing restenosis for the first year after implantation.
Anis, RR, Karsch, KR
openaire   +3 more sources

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. [PDF]

, 2007
BACKGROUND: The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death.
Kirtane, Ajay J, Schampaert, Erick, Dawkins, Keith D, Morice, Marie-Claude, Pocock, Stuart J, Fahy, Martin, Stone, Gregg W, Colombo, Antonio, Moses, Jeffrey W, Cutlip, Donald E, Ellis, Stephen G, Grube, Eberhard, Leon, Martin B, Mehran, Roxana, Schofer, Joachim   +14 more
core   +1 more source

An Analysis of Cost-Effectiveness of Stents Used in the Treatment of Coronary Artery Disease

Balkan Medical Journal, 2019
Background: There is only limited information about the cost-effectiveness of drug-eluting stents compared with bare-metal stents in Turkey. Aims: To evaluate bare-metal and drug-eluting stents used in the treatment of coronary artery disease from the ...
Ferda Işıkçelik, İsmail Ağırbaş, Cansın Tulunay Kaya   +2 more
doaj   +1 more source

A novel method of thrombelastograph analysis aids assessment of antiplatelet therapy in percutaneous coronary intervention. [PDF]

, 2010
MD (Research)Background A near-patient test of responses to antiplatelet therapy would be of great value in percutaneous coronary intervention (PCI). However, at present, there are no widely accepted tests and varied definitions of “resistance”.
Hobson, Alex
core   +4 more sources

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. [PDF]

, 2009
BACKGROUND: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI)
Brodie, Bruce R., Wong, S Chiu, Peruga, Jan Z., Parise, Helen, Möckel, Martin, Stone, Gregg W., Pocock, Stuart J, Witzenbichler, Bernhard, HORIZONS-AMI Trial Investigators, Stone, Gregg W, Dudek, Dariusz, Kellock, Alison, Gersh, Bernard J, Peruga, Jan Z, Lansky, Alexandra J, Ochala, Andrzej, Guagliumi, Giulio, Brodie, Bruce R, Lansky, Alexandra J., Pocock, Stuart J., Dangas, George, Gersh, Bernard J., Mehran, Roxana, Wong, S. Chiu   +23 more
core   +1 more source

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy

Case Reports in Medicine, 2009
Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term from those of bare-metal stents, late stent thrombosis after deployment of drug-eluting stents has emerged as a potential safety concern in the era of high-
Dirk Sibbing, Karl-Ludwig Laugwitz, Lorenz Bott-Flügel, Jürgen Pache   +3 more
doaj   +1 more source

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature

Heart Views, 2011
Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga, Mohammed Al-Mukhaini   +1 more
doaj   +1 more source

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis

Coronary Artery Disease, 2019
Approximately, 10-20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown. We sought to compare the outcomes of recurrent DES-ISR treated with drug eluting balloons (DEB) to those with repeated implantation of new-generation DES.A total of 172 ...
Wang, Guozhong, Zhao, Quanming, Chen, Qing, Zhang, Xiaoxia, Tian, Lei, Zhang, Xiaojiang   +5 more
openaire   +3 more sources

Drug Distribution and Stent Retention of Drug Eluting Stents [PDF]

, 2008
In this paper the examinations of drug eluting coronary stents are shown, such as the morphology of the coatings before expansion, drug distribution, the methodology and the value of stent retention.
Dobránszky, János, Balázs, T., Bognár, Eszter, Ring, Gy.   +3 more
core   +1 more source

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis

SAGE Open Medicine, 2014
Background: Reports regarding the relationship between the length and diameter of implanted drug-eluting stents and clinical and angiographic outcomes in dialysis patients are limited.
Hiroshi Fujita, Kenya Nasu, Mitsuyasu Terashima, Tsuyoshi Ito, Tomomitsu Tani, Takahiko Suzuki, Nobuyuki Ohte   +6 more
doaj   +1 more source